Skip to content

Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses

Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03942172
Enrollment
50
Registered
2019-05-08
Start date
2018-11-27
Completion date
2019-12-31
Last updated
2019-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

An open-label study to evaluate the effect of SpotOn balance glasses in non-demented Parkinson's patients with balance disorders.

Interventions

DEVICESpotOn balance glasses

SpotOn Balance Glasses comprising of personalized visual stimuli placed on the glasses's lenses

Sponsors

SpotOn Therapeutics Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Female or men 2. Diagnosed with Parkinson's disease (according to Brain Bank UK criteria) 3. Non-demented 4. Age: ≥ 30 years 5. Gait disturbances 6. Patients who are able to perform questionnaires and physical tests (including computerized tests) 7. Gave informed consent for participation in the study

Exclusion criteria

1. Unstable (less than 1 month) use of concomitant medications that might affect the balance system 2. Change of PD medications during the past month 3. Any medical condition or disorder that could produce gait or balance disturbances unless well controlled for at least 3 months 4. Blindness 5. Currently taking part in a clinical trial or within 30 days prior to screening 6. Any known condition which in the opinion of the investigator may impair gait or balance and/or limits the successful trial completion

Design outcomes

Primary

MeasureTime frameDescription
Unified Parkinson's disease rating scale3 weeksA comprehensive 50 question clinical rating scale for the assessment of both motor and non-motor symptoms associated with Parkinson's. The total cumulative score will range from 0 (no disability) to 199 (total disability).
TIMED UP AND GO (TUG)3 weeksThe TUG test is a physical performance measure in which the ability to rise up from a seated chair position, walk 3m, turn, walk back, and sit down is timed.
Berg Balance Scale (BBS)3 weeksThe BBS is a widely used clinical test of a person's static and dynamic balance abilities. t is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.A score of 56 indicates functional balance.
Non-Motor Symptoms Scale (NMSS)3 weeksThe non-motor symptoms questionnaire is a 30-point, patient-based questionnaire used to determine the non-motor symptoms experienced by the patient during the past month.Responses quantify symptoms according severity (using a scale of 0-3) and frequency (using a scale of 0-4). Higher scores represent more severe and more frequent symptoms.
39-item Parkinson's Disease Questionnaire (PDQ-39)3 weeksThis questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living. It is scored on a scale of 0-100, with lower scores indicating better health and high scores more severe symptoms.
Freeze of gait (FOG) Questionnaire3 weeksConsists of 16 items assessing freeze of gait. Total score ranges from 0 to 24, higher score corresponds to more severe FOG.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026